QuidelOrtho Reports Preliminary Q3 Revenues Of $738M-$744M Versus Consensus Of $655.33M
Portfolio Pulse from Benzinga Newsdesk
QuidelOrtho has reported preliminary Q3 revenues of $738M-$744M, surpassing the consensus of $655.33M. The non-respiratory product revenue is expected to be $557M-$560M, while the respiratory product revenue is projected to be $181M-$184M.
October 12, 2023 | 11:34 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
QuidelOrtho's Q3 revenues have exceeded expectations, which could positively impact the stock price of QDEL in the short term.
QuidelOrtho's Q3 revenues have surpassed the consensus, indicating strong financial performance. This could lead to increased investor confidence and a potential rise in QDEL's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100